Speciality Medicines' IPO was subscribed 2.19 times. The issue opened for bidding on 20 March 2026 and it closed on 24 March 2026. The price band of the IPO was fixed between Rs 117 to Rs 124 per share.
The IPO comprised fresh issue of 23,50,000 equity shares. The company intends to utilise the net proceeds for setting up a research and development (R&D) centre in Valsad, Gujarat; product registration in international markets; product development for sale in international markets; funding marketing and promotional activities; meeting working capital requirements and for general corporate purposes.
Speciality Medicines is involved in the marketing, distribution, and contract manufacturing of specialty pharmaceutical formulations used to treat complex and chronic conditions across areas such as oncology, immunology, neurology, and rare diseases. The company offers a broad portfolio of high-cost oral and injectable therapies in multiple dosage forms, including tablets, injections, inhalers, and infusions. Its operations are structured around two integrated models: contract manufacturing of approved formulations for international markets and the sourcing, marketing, and distribution of specialty pharmaceutical products from other manufacturers. As of 28 February 2026, the company had a total of 18 permanent employees across various departments.
The company recorded revenue from operations of Rs 36.72 crore and net profit of Rs 6.06 crore for the period ended 31 October 2025.
Powered by Capital Market - Live News
Beware of fraudulent tips, unauthenticated news and advice on stock market.
At BOB Capital, your account security is our topmost priority. Beware of receiving fraudulent communications, unauthenticated trading tips and unsolicited calls on trading in stocks from unverified sources, received through Whatsapp, Telegram, SMS, Calls, etc and take an informed decision before investing.
What should you do if you receive a trading tip over phone or SMS?
Report unsolicited messages to the Stock Exchange on +91 8291833676 or on designated email id i.e. feedbk_invg@nse.co.in. Please visit here to understand better.
Please visit CVC website at pledge.cvc.nic.in and take "Integrity Pledge" to be an active part of the "Satark Bharat, Samriddh Bharat" (Vigilant India, Prosperous India).
Filing complaints on SCORES - Easy & quick: a. Register on SCORES portal scores.sebi.gov.in/ b. Mandatory details for filing complaints on SCORES are i. Name, PAN, Address, Mobile Number, E-mail ID. c. Benefits: i. Effective communication ii. Speedy redressal of the grievances.
Valued Customer,
BOB Capital Markets Limited (BOBCaps) is firmly committed to the safety of your wealth. We would like to bring to your notice certain precautions that you certainly must take against potential tele-fraudsters/ unscrupulous and unregistered portfolio managers:
ALWAYS AVOID
We would like to caution you against such fraudulent calls and SMSes and urge you to be alert. Follow the golden rule:
Do not share your Login Credentials or Passwords with anybody
BOBCaps employees / representatives never ask for your password.
Certain tele-fraudsters / unscrupulous and unregistered portfolio managers call customers or SMS them on the pretext of providing investment tips and lure them to invest through their bogus firms by promising huge profits.
Such deceitful callers ask the customer to share his/her login credentials with passwords to allow trading in their accounts, assuring huge returns.
Often trades done in the customer’s accounts are far from the best interest of the customers. Holdings of customers are often sold and with the funds, trades are then placed in illiquid securities at unrealistic prices.
At times, the holdings of customers are sold at prices detrimental to the customer. The so-called “portfolio manager” assures profits, which naturally does not materialize. Customers are deceived into providing access to their trading accounts, thereby allowing such fraudsters access to funds and securities available to execute trades, injurious to the customer’s interest.
In our continuous effort to keep you safeguard from the market related frauds and increase awareness while conducting trades, we request you to go through the Press Release issued by the NSE and would request you to ensure that you do not engage with the individuals and entities mentioned below: